Literature DB >> 28475760

Evaluating patients' walking capacity during hospitalization for lung cancer resection.

Pedro A Esteban1, Nieves Hernández1, Nuria M Novoa1, Gonzalo Varela1.   

Abstract

OBJECTIVES: The goal of this study was to describe non-supervised daily physical activity in patients during the period immediately following anatomical lung resection.
METHODS: The study was an observational study on 50 consecutive patients (33 men) admitted for anatomical lung resection over a 4-month period. All cases were approached using a minimally invasive technique. Patients were instructed by nursing and physiotherapy staff and asked to wear a portable pedometer (Omron HJ-720 T-E2) from admission until hospital discharge, excluding the day of the operation and the first hours in the recovery room. The variables collected included sex, age, body mass index, type of lung resection, cardiopulmonary postoperative complications, percentage forced expiratory volume in 1 s, percentage single-breath carbon monoxide diffusing capacity, predicted postoperative forced expiratory volume in 1 s calculated according to functional segments removed at surgery, predicted postoperative single-breath carbon monoxide diffusing capacity calculated according to functional segments removed at surgery, total steps, aerobic steps and daily total strolled distance in metres. Comparison of activity was analysed using the paired t-test for individual data evolution and the unpaired t-test for patients showing complications or not. Body mass index and exercise capacity were analysed using the Spearman correlation analysis.
RESULTS: A total of 34 patients underwent lobectomy or bilobectomy. All patients could walk on the first postoperative day. The average walked distance on the first and fourth postoperative days was 6100 m and 7400 m, respectively. Compared with the preoperative day, patients walked significantly fewer total steps on Day 1 and Day 2 (Day 1, P = 0.0001; Day 2, P = 0.049). The rate of aerobic to total daily steps was comparable after the second postoperative day. Patients having any postoperative cardiopulmonary complication showed a significantly inferior walking capacity (P < 0.001), both preoperatively and postoperatively, than their peers without complications.
CONCLUSIONS: After anatomical lung resection, patients could perform a relevant amount of physical activity. These data could be useful for designing physical recovery programmes to be implemented postoperatively.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Exercise capacity; Lung cancer; Postoperative care; Pulmonary lobectomy

Mesh:

Year:  2017        PMID: 28475760     DOI: 10.1093/icvts/ivx100

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  Preoperative Physical Inactivity Affects the Postoperative Course of Surgical Patients with Lung Cancer.

Authors:  Yuki Kuroyama; Eiichi Geshi
Journal:  Phys Ther Res       Date:  2021-10-13

Review 2.  Physical activity in surgical lung cancer patients: a systematic review.

Authors:  Weijiao Zhou; Katelyn E Webster; Ellen Lavoie Smith; Weiyun Chen; Philip T Veliz; Rishindra M Reddy; Janet L Larson
Journal:  Support Care Cancer       Date:  2022-04-06       Impact factor: 3.603

3.  Digital chest drainage vs. water seal chest drainage in the robotic era.

Authors:  Nuria M Novoa; Marta G Fuentes
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

4.  Inspiratory Muscle Training in High-Risk Patients Following Lung Resection May Prevent a Postoperative Decline in Physical Activity Level.

Authors:  Barbara Cristina Brocki; Jan Jesper Andreasen; Elisabeth Westerdahl
Journal:  Integr Cancer Ther       Date:  2018-08-23       Impact factor: 3.279

Review 5.  Impact of preoperative exercise therapy on surgical outcomes in lung cancer patients with or without COPD: a systematic review and meta-analysis.

Authors:  Xiang Li; Shaolei Li; Shi Yan; Yaqi Wang; Xing Wang; Alan D L Sihoe; Yue Yang; Nan Wu
Journal:  Cancer Manag Res       Date:  2019-02-20       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.